메뉴 건너뛰기




Volumn 4, Issue 2, 2003, Pages 113-121

Receptor tyrosine kinases: The main targets for new anticancer therapy

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; ADENOSINE TRIPHOSPHATE; ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ETOPOSIDE; FLUDARABINE; FOLINATE CALCIUM; GEFITINIB; GEMCITABINE; IMATINIB; METHOTREXATE; ONCOPROTEIN; PREDNISONE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; STEM CELL FACTOR; TRASTUZUMAB; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANDETANIB; VASCULOTROPIN INHIBITOR; VASCULOTROPIN RECEPTOR; VATALANIB; VINCRISTINE;

EID: 0037313867     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033346885     Document Type: Review
Times cited : (92)

References (45)
  • 14
    • 0037080402 scopus 로고    scopus 로고
    • Joensuu, H. (2002) Med. Klin. 97(1), 28-30.
    • (2002) Med. Klin. , vol.97 , Issue.1 , pp. 28-30
    • Joensuu, H.1
  • 38
    • 0035257198 scopus 로고    scopus 로고
    • Miller, K. (2001) Oncology, 15, 38-40.
    • (2001) Oncology , vol.15 , pp. 38-40
    • Miller, K.1
  • 42


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.